Tower Research Capital »

Regentis Biomaterials shares owned by Tower Research Capital

Quarter-by-quarter ownership of Regentis Biomaterials (RGNT) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Regentis Biomaterials

Tip: Access up to 7 years of quarterly data

All positions including Regentis Biomaterials held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regentis Biomaterials by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $39 11 3.55

More positions owned by Tower Research Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Spdr Series Trust St Inter Bd Etf (SPIB)
Micron Technology (MU)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Intel Corporation (INTC)
Ishares Tr 0-3 Mth Treasury (SGOV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Tower Research Capital

Top funds holding Regentis Biomaterials

Rosalind Advisors
Warberg Asset Management
Jane Street
Renaissance Technologies
UBS Group
Tower Research Capital

View all funds holding Regentis Biomaterials